Zhiwei Wang
- Molecular Biology top 5%
- Cancer Research top 0.5%
- Oncology top 5%
- Pathology and Forensic Medicine top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Fazlul H. SarkarDejuan KongYiwei LiShadan AliTimothy VandenBoomPhilip A. PhilipAamir AhmadSanjeev Banerjee
- Topics
- MicroRNA in disease regulation (26 papers)Cancer-related molecular mechanisms research (17 papers)Circular RNAs in diseases (10 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhiwei Wang
37 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 2.4k
- Cancer Research 1.9k
- Oncology 765
- Pathology and Forensic Medicine 174
- Pulmonary and Respiratory Medicine 169
Countries citing papers authored by Zhiwei Wang
This map shows the geographic impact of Zhiwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwei Wang more than expected).
Fields of papers citing papers by Zhiwei Wang
This network shows the impact of papers produced by Zhiwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwei Wang. The network helps show where Zhiwei Wang may publish in the future.
Co-authorship network of co-authors of Zhiwei Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Zhiwei Wang. A scholar is included among the top collaborators of Zhiwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiwei Wang. Zhiwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 0 | |
| 6 | 7 | |
| 7 | 6 | |
| 8 | 27 | |
| 9 | 86 | |
| 10 | 63 | |
| 11 | 33 | |
| 12 | 35 | |
| 13 | 92 | |
| 14 | 90 | |
| 15 | 106 | |
| 16 | 79 | |
| 17 | 176 | |
| 18 | 38 | |
| 19 | Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cellsbreakdown → | 552 |
| 20 | 13 |
About Zhiwei Wang
Zhiwei Wang is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 40 papers that have together received 3.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (26 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (10 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (2.4k citations) and Molecular Medicine (154 citations). Zhiwei Wang has collaborated with scholars based in China and United States. Frequent co-authors include Fazlul H. Sarkar, Dejuan Kong, Yiwei Li, Shadan Ali, Timothy VandenBoom, Philip A. Philip, Aamir Ahmad, Sanjeev Banerjee, Yiwei Li and Jun Xia. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.